Review Article
Volume 15 Issue 7 - 2019
Approach to Thyrotoxicosis
Sherif Aly Emad Aldain Abueldahb1*, Hassan Ibrahim AlHassar2, Mansour A Arishi3, Abdulkareem Khalid S Bagar4, Mustafa Saeed Almahasnah5, Yousef Mohammed Ahmed Alghazali6, Sameer Ahmed Ali Almoraihel2, Eman Salman Alsalam7, Tahany Amesh Saad Alarjawe8, Shahad Mohammed Awad Alhazmi8 and Ibtihal Abbas Mohammad Al Ithan9
1Consultant of Internal Medicine, AL Zahraa Hospitals, Sherifaly, Saudi Arabia
2ALjafr General Hospital, Saudi Arabia
3King Khalid Hospital-Tabuk, Saudi Arabia
4Medical University of Gdansk, Saudi Arabia
5Khafji General Hospital, Saudi Arabia
6International Medical Center, Saudi Arabia
7Zhejiang University, Hangzhou-China
8University of Hail, Saudi Arabia
9Management of Health Centers - AlHasa, Saudi Arabia
*Corresponding Author: Sherif Aly Emad Aldain Abueldahb, Consultant of Internal Medicine, AL Zahraa Hospitals, Sherifaly, Saudi Arabia.
Received: June 14, 2019; Published: July 01, 2019


Introduction: Thyrotoxicosis is considered to be one of the common medical conditions. It is generally known to be associated with increasing levels of thyroid hormones circulating in the blood. Thyrotoxicosis might clinically present in several presentations and therefore could be faced by physicians in different medical specialties. In Europe, it impacts about one in two thousand patients every year. Despite the fact that thyrotoxicosis usually manifests with decreased weight, intolerance to heat, and increased heart rate, there are a many other additional manifestations, which present more variably with older age and in patients with relatively mild conditions. It is essential to detect the cause of the thyrotoxicosis, as this helps plan management. Some professionals distinguish between hyperthyroidism and thyrotoxicosis by restricting the former term to explain the cases associated with increased secretion and synthesis of the hormones of the thyroid from the thyroid gland. This clinical review summarizes the latest evidence for the diagnosis and treatment of adult patients with thyrotoxicosis.

Aim of Work: In this review, we will discuss thyrotoxicosis.

Methodology: We did a systematic search for approach to thyrotoxicosis using PubMed search engine ( and Google Scholar search engine ( All relevant studies were retrieved and discussed. We only included full articles.

Conclusions: Thyrotoxicosis is considered to be one of the common medical conditions. It is generally known to be associated with increasing levels of thyroid hormones circulating in the blood. Decreased weight, intolerance to heat, increased heart rate, tremors, agitation, and exhaustion are generally common clinical manifestations of thyrotoxicosis. The present treatment options for hyperthyroid Graves’ disease are thionamide pharmacological agents, using radioiodine, or undergoing thyroid surgery (thyroidectomy). Β-blockers (like propranolol modified release one or two times a day) are beneficial to control clinical manifestations in all thyrotoxicosis patients.

Keywords: Thyrotoxicosis; Approach; Management; Diagnosis; Treatment


  1. Garmendia Madariaga A., et al. “The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis”. Journal of Clinical Endocrinology and Metabolism 99.3 (2014): 923-931.
  2. Matos-Santos A., et al. “Relationship between the number and impact of stressful life events and the onset of Graves’ disease and toxic nodular goiter”. Clinical Endocrinology 55.1 (2001): 15-19.
  3. Effraimidis G., et al. “Involvement of stress in the pathogenesis of autoimmune thyroid disease: a prospective study”. Psychoneuroendocrinology 37.8 (2012): 1191-1198.
  4. Benhaim Rochester D and Davies TF. “Increased risk of Graves’ disease after pregnancy”. Thyroid 15.11 (2005): 1287-1290.
  5. Weetman AP. “Graves’ disease following immune reconstitution or immunomodulatory treatment: should we manage it any differently?” Clinical Endocrinology 80.5 (2014): 629-632.
  6. Pearce SH and Merriman TR. “Genetics of type 1 diabetes and autoimmune thyroid disease”. Endocrinology and Metabolism Clinics of North America 38.2 (2009): 289-301.
  7. De Groot L., et al. “Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline”. Journal of Clinical Endocrinology and Metabolism 97.8 (2012): 2543-2565.
  8. Boelaert K., et al. “Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study”. Journal of Clinical Endocrinology and Metabolism 95.6 (2010): 2715-2726.
  9. Chang CC., et al. “A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants”. European Journal of Endocrinology 169.5 (2013): 529-536.
  10. Akamizu T., et al. “Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys”. Thyroid 22.7 (2012): 661-679.
  11. Tozzoli R., et al. “TSH receptor autoantibody immunoassay in patients with Graves’ disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis”. Autoimmunity Reviews 12.2 (2012): 107-113.
  12. Sundaresh V., et al. “Comparative effectiveness of therapies for Graves’ hyperthyroidism: a systematic review and network meta-analysis”. Journal of Clinical Endocrinology and Metabolism 98.9 (2013): 3671-3677.
  13. Cooper DS and Rivkees SA. “Putting propylthiouracil in perspective”. Journal of Clinical Endocrinology and Metabolism 94.6 (2009): 1881-1882.
  14. Abraham P., et al. “Antithyroid drug regimen for treating Graves’ hyperthyroidism”. Cochrane Database of Systematic Reviews 1 (2010): CD003420.
  15. Nakamura H., et al. “Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan”. Journal of Clinical Endocrinology and Metabolism 98.12 (2013): 4776-4783.
  16. Allahabadia A., et al. “Age and gender predict the outcome of treatment for Graves’ hyperthyroidism”. Journal of Clinical Endocrinology and Metabolism 85.3 (2000): 1038-1042.
  17. Bartalena L., et al. “Consensus statement of the European group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy”. Thyroid 18.3 (2008): 333-346.
Citation: Sherif Aly Emad Aldain Abueldahb., et al. “Approach to Thyrotoxicosis”.”. EC Microbiology 15.7 (2019): 646-652.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for October Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the November issue of respective journals. Submissions are accepted on/before October 07, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to